Consolidated Statements of Equity (As Restated) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Mar. 31, 2014	2,355,027
Balance at Mar. 31, 2014	$ 588,756	$ 4,855,093	$ 21,923,988	$ (7,780)		$ 27,360,057
Net income			2,483,926			2,483,926
Unrealized gain (loss) from marketable securities, net of tax				(127,133)		$ (127,133)
Exercise of stock options (in shares)	17,500					17,500
Exercise of stock options	$ 4,375	146,375				$ 150,750
Compensation expense related to stock options		8,958				8,958
Tax effect from exercise, forfeiture and repurchase of stock options		49,000				49,000
Repurchase of stock options		(130,335)				(130,335)
Initial consolidation of Delphax
Balance (in shares) at Mar. 31, 2015	2,372,527
Balance at Mar. 31, 2015	$ 593,131	4,929,090	24,407,915	(134,913)		29,795,223
Net income			4,413,910		(655,953)	3,757,957	[1],[2],[3]
Unrealized gain (loss) from marketable securities, net of tax				46,657		46,657
Compensation expense related to stock options		19,653			9,681	29,334
Initial consolidation of Delphax					1,712,935	1,712,935	[1]
Foreign currency translation loss				(52,263)	(25,741)	(78,004)
Funding on residual sharing agreements		7,428				7,428
Balance (in shares) at Mar. 31, 2016	2,372,527
Balance at Mar. 31, 2016	$ 593,131	$ 4,956,171	$ 28,821,825	$ (140,519)	$ 1,040,922	$ 35,271,530	[4]

[1] The Consolidated Statement of Cash Flow for the year ended March 31, 2016 has been restated. See Note 1A.

[2] The Consolidated Statement of Comprehensive Income for the year ended March 31, 2016 has been restated. See Note 1A.

[3] The Consolidated Statement of Comprehensive Income for the year ended March 31, 2016 has been restated. See Note 1A.

[4] The Consolidated Balance Sheet as of March 31, 2016 has been restated. See Note 1A.